• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

T is great, including the sales

anonymous

Guest
All of these ridiculous posts about how Toxic T is…dude, it did $360m plus for 2021 (look it up). This is hardly the $100m people kept quoting. T is a great therapy, just have to manage side effects.
Move on people….
 








All of these ridiculous posts about how Toxic T is…dude, it did $360m plus for 2021 (look it up). This is hardly the $100m people kept quoting. T is a great therapy, just have to manage side effects.
Move on people….

Stop it! $360+M is nothing compared to all of the billions in dough that has been wasted on the Oncology BU. Nowhere near ROI for the total waste of dollars.
 
















All of these ridiculous posts about how Toxic T is…dude, it did $360m plus for 2021 (look it up). This is hardly the $100m people kept quoting. T is a great therapy, just have to manage side effects.
Move on people….
Wow talk about spin zone. Nobody mentioned 100mil. 1 post said 100mil last Q which is FLAT & declining as if even suatained flat would be 400m annually.
All said 250-350m which is way way under 1.5billion year forcasted by Wall Street when Gilead bought Immunomedics...... they sold Gilead swamp land marketed as a Diamond mine.
Trov is very toxic and 90% patients can not tolerate & switch to less Side Effect agents.
FACT.....
Good luck believing lies.
With recent FDA 2yr delay of Mal , within 5yrs Gilead sells off Onc as it was huge mistake by previous CEO and current CEO just trying to salavage the crap that was sold to Gilead
 




holy cow the data sucked and your cfo was fumbling all over himself during the call. Then your legal team had to release an 8k to SEC after his statements trying to cover up the facts.
Read between the lines people this is going to get ugly.


Wow talk about spin zone. Nobody mentioned 100mil. 1 post said 100mil last Q which is FLAT & declining as if even suatained flat would be 400m annually.
All said 250-350m which is way way under 1.5billion year forcasted by Wall Street when Gilead bought Immunomedics...... they sold Gilead swamp land marketed as a Diamond mine.
Trov is very toxic and 90% patients can not tolerate & switch to less Side Effect agents.
FACT.....
Good luck believing lies.
With recent FDA 2yr delay of Mal , within 5yrs Gilead sells off Onc as it was huge mistake by previous CEO and current CEO just trying to salavage the crap that was sold to Gilead
 








holy cow the data sucked and your cfo was fumbling all over himself during the call. Then your legal team had to release an 8k to SEC after his statements trying to cover up the facts.
Read between the lines people this is going to get ugly.

This drug is about as effective as the current administration. 2 more years before we have any hope and it’s going to get a lot worse before it can get better.
 




All of these ridiculous posts about how Toxic T is…dude, it did $360m plus for 2021 (look it up). This is hardly the $100m people kept quoting. T is a great therapy, just have to manage side effects.
Move on people….
Funny, 300mil is nothing when T costs $17,000 for the 1st cycle.
Ask the patients like me who have taken it, it is down right nasty times 10.
Keep drinking the koolaide
 
























It will never be used 1st line Gold Standard & will need half dozen other compounds in the IG pipeline to come out just to break even on the purchase price.
Swamp land sold allowed execs to retire on private islands & laugh all way to bank (you wonder why the big Onc players Merck, AZ, BMS, Novartis all passed & kicked IG to curb when approached? Well only takes 1 blind co to fool & take the bait! Now Dan is stuck w salvaging what previous CEO spent billions on.
Time to sell what can & go back to what made Gilead soar until 6yrs years when old CEO went crazy buying things outside of expertise & now past 6yrs stock has crashed & flat at bottom range. Cut bait & sale for whatever can get then go back to virology & immunology to get stock soaring again. Onc is dead & sucks up alot of money w no positive ROI for next 20yrs